About Samsung Biologics America
Samsung Biologics America is our U.S. subsidiary committed to providing trusted services to our clients and industry partners. As part of our expansion efforts, we have established the San Francisco R&D Center to support our CDO services and a New Jersey office to enable close communication with current and potential clients worldwide.
- San Francisco R&D Center
- 600 Gateway Blvd., South San Francisco, CA 94080, USA
- New Jersey Office
- 100 Challenger Rd, Ridgefield Park, NJ 07660, USA
Service & Facility
The San Francisco R&D Center uses industry-standard equipment, including Cytena Single Cell Printer and Solentim Cell Metric, to perform Cell Line Development (CLD) as fast as 14 weeks (or 3.5 months). Samsung Biologics offers its own proprietary cell line development technology S-CHOice®, which builds on glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line technology and shows improved titers up to two-fold from the industry average, reaching above 7 g/L for standard monoclonal antibodies. Our high expression cell line maintains viability over 90% at day-21 in a fed-batch study, demonstrating effectiveness in producing high quality cell lines.
-
Transfect
CHO GS
KO host with
vector -
Stable pool
generation &
selection of
high-producing pools ~7 weeks -
Single cell
cloning ~ 3 weeks -
Stable clone
generation &
RCB selection ~ 4 weeks